Absci Company
Integrated Drug Creation™ platform combines generative AI with scalable wet-lab technologies to design and validate novel antibodies.
Investors
%20LLC.png)
Industry:
Early Drug Development
Total Funding:
~$500 M
Headquarters:
USA
Founded Date:
2011
Employee Number:
101-250